J&J to buy Cougar for $1 billion

22 May 2009

• By Sita Shah

Johnson & Johnson is to buy oncology specialist Cougar Biotechnology for $1 billion in cash to boost its pipeline of late-stage cancer therapeutics.

More from Anticancer